+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GUJTHEM

Gujarat Themis Biosyn Share Price

₹381.80 -5.8 (-1.5%)
69.65% Gain from 52W Low

01 Oct, 2026 3:59 PM (IST)

Gujarat Themis Biosyn live price: ₹381.80. It opened at ₹385 vs previous close ₹388; intraday high/low: ₹395/₹369. The 50 & 200 DMA stand at ₹398.20/₹371.00.

Gujarat Themis Biosyn Performance

  • Today's Low
  • ₹369
  • Today's High
  • ₹395
  • 52 Week Low
  • ₹225
  • 52 Week High
  • ₹479
  • Open Price₹385
  • Previous Close₹388
  • Volume425,166
  • 50 DMA₹398.20
  • 100 DMA₹385.50
  • 200 DMA₹371.00

Gujarat Themis Biosyn Chart

Investment Returns

  • Over 1 Month -9.57%
  • Over 3 Month -3.95%
  • Over 6 Month + 68.27%
  • Over 1 Year -3.28%

Smart Investing Starts Here Start SIP with Gujarat Themis Biosyn for Steady Growth!

Invest Now

Gujarat Themis Biosyn Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 102.1
  • PEG Ratio
  • 11.1
  • Market Cap Cr
  • 4,969
  • P/B Ratio
  • 16.5
  • Average True Range
  • 20.2
  • EPS
  • 3.7
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -1.2
  • RSI
  • 40.38
  • MFI
  • 56.38

Latest Stock News Updates

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Please refer to our Scrutinizer Report and Voting Results of 45th Annual General Meeting counter signed by the Chairman.

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Please refer to our counter signed Scrutinizer''s Report of 45th Annual General Meeting.

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Kindly refer to the attachment.

Gujarat Themis Biosyn Financials

Gujarat Themis Biosyn Technicals

EMA & SMA

Current Price
₹381.80
-5.8 (-1.5%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹406.90
  • 50 Day
  • ₹398.20
  • 100 Day
  • ₹385.50
  • 200 Day
  • ₹371.00

Resistance and Support

381.8 Pivot Speed
  • R3 421.40
  • R2 408.20
  • R1 395.00
  • S1 368.60
  • S2 355.40
  • S3 342.20

Gujarat Themis Biosyn Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-10 Others
2026-09-01 Preferential issue of shares
2026-08-07 Quarterly Results
2026-06-19 To consider Fund Raising (Cancelled )
2026-06-06 Fund Raising & Others To consider other business matters.
Date Purpose Remarks
2026-09-23 FINAL Rs.0.67 per share(67%)Final Dividend
2025-09-05 FINAL Rs.0.67 per share(67%)Final Dividend
2024-02-22 INTERIM Rs.0.75 per share(75%)Interim Dividend
2022-12-02 INTERIM Rs.4.40 per share(88%)Interim Dividend
2021-11-25 INTERIM Rs.2.00 per share(40%)Interim Dividend
View Gujarat Themis Biosyn Dividend History Arrow
Date Purpose Remarks
2023-10-10 Split Stock split from Rs. 5/- to Re. 1/-.
Date Purpose Remarks
2024-08-09 Bonus Bonus issue in the ratio of 1:2 of Re. 1/-.

Gujarat Themis Biosyn Shareholding Pattern

70.86%
26.18%
1.76%
1.16%
0.01%

About Gujarat Themis Biosyn

Gujarat Themis Biosyn is principally engaged in the activities pertaining to manufacturing of Bulk Drugs. View More
  • NSE Symbol
  • GUJTHEM
  • BSE Symbol
  • 506879
  • ISIN
  • INE942C01045

Similar Stocks to Gujarat Themis Biosyn

Gujarat Themis Biosyn FAQs

Gujarat Themis Biosyn share price is ₹381 As on 02 October, 2026 | 06:28

The Market Cap of Gujarat Themis Biosyn is ₹4969.2 Cr As on 02 October, 2026 | 06:28

The P/E ratio of Gujarat Themis Biosyn is 102.1 As on 02 October, 2026 | 06:28

The PB ratio of Gujarat Themis Biosyn is 16.5 As on 02 October, 2026 | 06:28

The 52 week High & Low of Gujarat Themis Biosyn is ₹479/₹225 respectively As on 02 October, 2026 | 06:28

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23